US Biopsy manufactures soft-tissue biopsy products, such as the TLAB Transjugular Liver Biopsy Instrument. Through the acquisition, Argon Medical becomes one of two companies competing in the transjugular biopsy market, according to the company.
“This acquisition allows us to leverage our current soft tissue biopsy portfolio and further demonstrates our commitment to growth in the interventional space,” said Argon Medical president George Leondis.
More articles on acquisitions:
Mylan to acquire U.S. rights for Aspen injection
SSM Health Care to acquire Audrain County Health Department’s home health, hospice division
Covidien acquires medical device firm Sapheon
